Your browser doesn't support javascript.
loading
Application of Mendelian randomization to explore the causal role of the human gut microbiome in colorectal cancer.
Hatcher, Charlie; Richenberg, George; Waterson, Samuel; Nguyen, Long H; Joshi, Amit D; Carreras-Torres, Robert; Moreno, Victor; Chan, Andrew T; Gunter, Marc; Lin, Yi; Qu, Conghui; Song, Mingyang; Casey, Graham; Figueiredo, Jane C; Gruber, Stephen B; Hampe, Jochen; Hampel, Heather; Jenkins, Mark A; Keku, Temitope O; Peters, Ulrike; Tangen, Catherine M; Wu, Anna H; Hughes, David A; Rühlemann, Malte C; Raes, Jeroen; Timpson, Nicholas J; Wade, Kaitlin H.
Afiliação
  • Hatcher C; MRC Integrative Epidemiology Unit, University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, UK.
  • Richenberg G; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, BS8 2BN, UK.
  • Waterson S; MRC Integrative Epidemiology Unit, University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, UK.
  • Nguyen LH; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, BS8 2BN, UK.
  • Joshi AD; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, BS8 2BN, UK.
  • Carreras-Torres R; North Bristol NHS Trust, Bristol, BS10 5NB, UK.
  • Moreno V; Massachusetts General Hospital, Boston, MA, 02114, USA.
  • Chan AT; Massachusetts General Hospital, Boston, MA, 02114, USA.
  • Gunter M; Colorectal Cancer Group, ONCOBELL Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908, Barcelona, Spain.
  • Lin Y; Digestive Diseases and Microbiota Group, Girona Biomedical Research Institute (IDIBGI), 17190, Salt, Girona, Spain.
  • Qu C; Colorectal Cancer Group, ONCOBELL Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908, Barcelona, Spain.
  • Song M; Oncology Data Analytics Program, Catalan Institute of Oncology (ICO), Hospitalet de Llobregat, Barcelona, Spain.
  • Casey G; Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), Madrid, Spain.
  • Figueiredo JC; Department of Clinical Sciences, Universitat de Barcelona Institute of Complex Systems (UBICS), Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.
  • Gruber SB; Massachusetts General Hospital, Boston, MA, 02114, USA.
  • Hampe J; International Agency for Research on Cancer, 150 Cours Albert Thomas, 69372, Lyon, CEDEX 08, France.
  • Hampel H; Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. N., Seattle, WA, 98109, USA.
  • Jenkins MA; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Keku TO; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA.
  • Peters U; Division of Gastroenterology, Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02115, USA.
  • Tangen CM; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA.
  • Wu AH; Center for Public Health Genomics, University of Virginia, Charlottesville, VA, USA.
  • Hughes DA; Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Rühlemann MC; Department of Preventive Medicine, USC Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Raes J; Department of Medicine I, University Hospital Dresden, Technische Universität Dresden (TU Dresden), Dresden, Germany.
  • Timpson NJ; Division of Human Genetics, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
  • Wade KH; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia.
Sci Rep ; 13(1): 5968, 2023 04 12.
Article em En | MEDLINE | ID: mdl-37045850
ABSTRACT
The role of the human gut microbiome in colorectal cancer (CRC) is unclear as most studies on the topic are unable to discern correlation from causation. We apply two-sample Mendelian randomization (MR) to estimate the causal relationship between the gut microbiome and CRC. We used summary-level data from independent genome-wide association studies to estimate the causal effect of 14 microbial traits (n = 3890 individuals) on overall CRC (55,168 cases, 65,160 controls) and site-specific CRC risk, conducting several sensitivity analyses to understand the nature of results. Initial MR analysis suggested that a higher abundance of Bifidobacterium and presence of an unclassified group of bacteria within the Bacteroidales order in the gut increased overall and site-specific CRC risk. However, sensitivity analyses suggested that instruments used to estimate relationships were likely complex and involved in many potential horizontal pleiotropic pathways, demonstrating that caution is needed when interpreting MR analyses with gut microbiome exposures. In assessing reverse causality, we did not find strong evidence that CRC causally affected these microbial traits. Whilst our study initially identified potential causal roles for two microbial traits in CRC, importantly, further exploration of these relationships highlighted that these were unlikely to reflect causality.
Assuntos

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Colon_e_reto Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Microbioma Gastrointestinal Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: Sci Rep Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Colon_e_reto Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Microbioma Gastrointestinal Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: Sci Rep Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido